Doses of BioNTech bivalent coronavirus disease (COVID-19) vaccine are pictured at a private clinic in Hong Kong, China January 12, 2023. REUTERS/Tyrone Siu
Doses of BioNTech bivalent coronavirus disease (COVID-19) vaccine are pictured at a private clinic in Hong Kong, China January 12, 2023. REUTERS/Tyrone Siu